Dr. Carine Azar

Specialist – Neurology

Dr. Carine Azar, Specialist – Neurology graduated from the Saint Joseph University in Beirut, Lebanon and completed her specialist training in Neurology from Hotel Dieu De France, Lebanon and Pitié Salpêtrière Hospital, Paris. Dr. Azar was awarded the Diploma of Specialized Medical Training from the University of Paris Diderot in France and the diploma of Clinical Neurophysiological Explorations from Sorbonne University in Paris, France.

Her special interest is in Neurophysiology (Nerve Conduction Studies, Electromyography – EMG and Evoked Potentials), Peripheral Nerve Disorders, Multiple Sclerosis, Movement Disorders including Parkinson’s disease and Dystonia and Botulinum Toxin Injections in Neurology.

Dr Azar has also been an eminent academician, attending and presenting posters and conferences in many congresses around the world such as the European Academy of Neurology congress in Oslo in 2019, the World Congress of Neurology in Dubai in 2019 and the JNLF (Journées de Neurologie de Langue Française) in France in 2017, 2018 and 2019. She also has publications in European and international journals and is a member of several neurology and neurophysiology societies (European and International).


  • Member of the European Academy of Neurology
  • Member of the International Neurotoxin Association (Botulinum Toxin)
  • Member of the international Federation of Clinical Neurophysiology
  • Member of the International Parkinson and Movement Disorder Society


  • Certified in Neurophysiology, ENMG and evoked potentials (Neurophysiology Diploma from Sorbonne University, Paris, France)
  • Ongoing Certification for Botulinum toxin for movement disorders (dystonia, facial spasms)

She is fluent in Arabic, French and English.


  • Peripheral Disorders (Peripheral neuropathies, diabetic neuropathy, demyelinating neuropathy and Guillain Barré syndrome, muscle disorders, neuromuscular junction disorders such as Myasthenia Gravis and Lambert Eaton myasthenic syndrome (LEMS), motor neuron disorders, pain disorders, genetic and metabolic disorders with implication of the peripheral nervous system, pain management)
  • Movement Disorders such as tremor, dystonia, chorea, myoclonus.
  • Parkinson’s disease in early and late stages and treatment with therapies such as subcutaneous apomorphine
  • Multiple Sclerosis management and other CNS inflammatory diseases (NMO, MOG)
  • Seizure disorders, such as epilepsy and convulsions
  • Autoimmune encephalitis and paraneoplastic disorders
  • Sleep disorders and Restless leg syndrome
  • Headache disorders, migraine, trigeminal Neuralgia
  • Neurodegenerative disorders, such as Alzheimer’s disease, other dementias and amyotrophic lateral sclerosis
  • Facial palsy and complications
  • Vertigo, dizziness, gait and balance disorders
  • Speech, language and swallowing disorders
  • Memory and behavioral disorders
  • Spinal cord disorders
  • Metabolic and genetic disorders with implication of the nervous system